Instituto de Efectividad Clínica y Sanitaria (IECS), Emilio Ravignani 2024, C1414CPV, Buenos Aires, Argentina.
Facultad de Ciencias Médicas (UNLP), La Plata, Argentina.
High Blood Press Cardiovasc Prev. 2023 May;30(3):281-288. doi: 10.1007/s40292-023-00580-7. Epub 2023 May 18.
One of the self-report adherence scales most widely used is the 8-item Morisky Medication Adherence Scale (MMAS-8).
To evaluate construct validity and reliability of the MMAS-8 in hypertensive adults from low-resource settings within the public primary care level in Argentina.
Prospective data from hypertensive adults under antihypertensive pharmacological treatment that participated in the "Hypertension Control Program in Argentina" study was analyzed. Participants were followed at baseline, 6, 12 and 18 months. Based on MMAS-8, adherence was defined as low (score < 6), medium (score 6 to < 8) and high (score of 8).
1214 participants were included in the analysis. In comparison to low adherence, high adherence category was associated with a reduction of - 5.6 mmHg (CI 95%: - 7.2; - 4.0) in systolic blood pressure (BP) and - 3.2 mmHg (CI 95%: - 4.2; - 2.2) in diastolic BP; and with a 56% higher likelihood to have controlled BP (p < .0001). Among those participants with baseline score ≤ 6, two points increase in MMAS-8 along follow-up showed a tendency to reduce BP in almost all-time points and a 34% higher likelihood of having controlled BP at the end of the follow-up (p = 0.0039). Cronbach's alpha total-item values in all time-points were higher than 0.70.
Higher MMAS-8 categories were positively associated with BP reduction and higher likelihood of BP control over time. Internal consistency was acceptable and in line with previous studies.
最广泛使用的自我报告依从性量表之一是 8 项 Morisky 药物依从性量表(MMAS-8)。
评估 MMAS-8 在阿根廷公共初级保健水平下资源匮乏环境中高血压成年人中的构念效度和信度。
对参加“阿根廷高血压控制计划”研究的接受降压药物治疗的高血压成年人的前瞻性数据进行了分析。参与者在基线、6、12 和 18 个月时进行随访。根据 MMAS-8,将依从性定义为低(得分<6)、中(得分 6-<8)和高(得分 8)。
共纳入 1214 名参与者进行分析。与低依从性相比,高依从性类别与收缩压(BP)降低 -5.6mmHg(95%CI:-7.2;-4.0)和舒张压(BP)降低 -3.2mmHg(95%CI:-4.2;-2.2)相关;且血压控制的可能性增加 56%(p<0.0001)。在基线得分≤6 的参与者中,MMAS-8 评分在随访期间增加 2 分,几乎在所有时间点均显示出降低血压的趋势,并且在随访结束时血压控制的可能性增加 34%(p=0.0039)。所有时间点的 MMAS-8 总项目值的克朗巴赫α值均高于 0.70。
较高的 MMAS-8 类别与 BP 降低和随时间推移血压控制的可能性增加呈正相关。内部一致性是可接受的,与先前的研究一致。